You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》歸創通橋(02190.HK)公開超購1,189倍及上限定價 一手中籤率僅2%
阿思達克 07-02 08:21
內地神經和外周血管介入醫療器械公司歸創通橋-B(02190.HK)公布招股結果,計劃發行6,000萬股H股,原計劃當中10%在港公開發售,本港公開發售錄大幅超購1,189.37倍(獲43.8萬份申請),經重新分配後,公開發售股數增至50%,根據國際發售初步提呈發售的發售股份獲大幅超購21.5倍。

每股發售價定於42.7元,為上限定價(原招股價每股介乎39.8至42.7元),認購一手500股僅中籤率為2%,要認購200手(即10萬股)才穩獲一手。該股將於下周一(7月5日)上市,摩根士丹利及中信證券為聯席保薦人。

公司引入12名基石投資者,包括高瓴資本、富達國際、清池資本、博裕資本、AIHC、Hudson Bay及雪湖資本等,合共認購2,635.6萬股股份,佔全球發售完成後公司已發行股本總額約8.15%。

公司預計集資淨額為23.98億元,當中37%將用於核心產品上;11%用於其他5個主要產品的持續研發、生產和商業化;40%用於其他38款產品及在研管線;3%用於進一步升級研發設施;4%用於潛在戰略收購、投資、授權引進或合作;及餘下5%用於營運資金和一般公司用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account